- 1. DOC-1R
- [Ubiquitous 126-aa 13-kDa Tumor Suppressor Deleted In Oral Cancer-Related 1 protein is encoded by human DOC-1R Gene (DOC1 Family). (NCI) ( NCI )] (UMLS (NCI) C0910618) DOC-1R Protein;
Tumor Suppressor Deleted in Oral Cancer-Related 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 42. Docetaxel/Oxaliplatin
- (UMLS (NCI) C0879411) =Therapeutic or Preventive Procedure
|
- 2. Docarpamine
- (UMLS (NCI) C0075755) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 43. Docetaxel/R101933
- (UMLS (NCI) C1134556) =Therapeutic or Preventive Procedure ;
|
- 3. Docetaxel Anhydrous
- [The anhydrous form of docetaxel, a semisynthetic side-chain analogue of paclitaxel with antineoplastic property. Docetaxel binds specifically to the beta-tubulin subunit of microtubules and thereby antagonizes the disassembly of the microtubule proteins. This results in the persistence of aberrant microtubule structures and results in cell-cycle arrest and subsequent cell death. ( NCI )] (UMLS (NCI) C0771375) DOCETAXEL, ANHYDROUS =Organic Chemical; Pharmacologic Substance
| - 44. Docetaxel/Sulindac
- (UMLS (NCI) C1134670) =Therapeutic or Preventive Procedure
|
- 4. Docetaxel/DN-101
- (UMLS (NCI) C1328170) =Therapeutic or Preventive Procedure; ;
| - 45. Docetaxel/Suramin
- (UMLS (NCI) C1328022) =Therapeutic or Preventive Procedure; ;
|
- 5. Docetaxel/Doxorubicin
- (UMLS (NCI) C0392970) =Therapeutic or Preventive Procedure ;
| - 46. Docetaxel/Tamoxifen
- (UMLS (NCI) C0935785) =Therapeutic or Preventive Procedure ;
|
- 6. Docetaxel/Doxorubicin HCl Liposome
- (UMLS (NCI) C0678063) =Therapeutic or Preventive Procedure ;
| - 47. Docetaxel/Tariquidar
- (UMLS (NCI) C1328077) =Therapeutic or Preventive Procedure ;
|
- 7. Docetaxel/Doxorubicin Hcl Liposome/Trastuzumab
- (UMLS (NCI) C0879443) =Therapeutic or Preventive Procedure ;
| - 48. Docetaxel/Thalidomide
- (UMLS (NCI) C0879429) =Therapeutic or Preventive Procedure
|
- 8. Docetaxel/Doxorubicin/Oblimersen
- (UMLS (NCI) C1327995) =Therapeutic or Preventive Procedure ;
| - 49. Docetaxel/TLK286
- (UMLS (NCI) C1328041) =Therapeutic or Preventive Procedure ;
|
- 9. Docetaxel/Doxorubicin/Tamoxifen
- (UMLS (NCI) C0796522) DOX/TMX/TXT =Therapeutic or Preventive Procedure
| - 50. Docetaxel/Trastuzumab
- (UMLS (NCI) C0879507) =Therapeutic or Preventive Procedure ;
|
- 10. Docetaxel/Epirubicin
- (UMLS (NCI) C0392962) =Therapeutic or Preventive Procedure ;
| - 51. Docetaxel/Vinorelbine
- (UMLS (NCI) C0338251) =Therapeutic or Preventive Procedure
|
- 11. Docetaxel/Epirubicin/Filgrastim
- (UMLS (NCI) C0392963) =Therapeutic or Preventive Procedure ;
| - 52. Docetaxel/ZD6474
- (UMLS (NCI) C1327880) =Therapeutic or Preventive Procedure ;
|
- 12. Docetaxel/Epirubicin/Pegfilgrastim
- (UMLS (NCI) C1328016) =Therapeutic or Preventive Procedure; ;
| - 53. dociton
- [ ] (UMLS (CSP) C0700770) =Organic Chemical; Pharmacologic Substance
|
- 13. Docetaxel/Erlotinib
- (UMLS (NCI) C1327739) =Therapeutic or Preventive Procedure ;
| - 54. Docking Protein 1
- [Docking Protein 1, encoded by the human DOK1 gene, interacts with receptor tyrosine kinases and mediates particular biological responses. This 62-kD protein is associated with p120 Ras-GAP and this association is correlated with its tyrosine phosphorylation. It is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. It plays an important role in mitogenic signaling and its aberrant phosphorylation may contribute to the progression of different human diseases. It is phosphorylated by the insulin receptor kinase, resulting in the negative regulation of the insulin signaling pathway. (From LocusLink, Swiss-Prot, OMIM and NCI) ( NCI )] (UMLS (NCI) C1333311) Docking Protein 1 (Downstream of Tyrosine Kinase 1);
Docking Protein 1, 62kD (Downstream of Tyrosine Kinase 1);
Docking Protein, 62-kD;
DOK1;
Downstream of Trosine Knase 1;
p62(DOK);
p62DOK;
pp62;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 14. Docetaxel/Estramustine
- (UMLS (NCI) C0677761) =Therapeutic or Preventive Procedure
| - 55. Docking Protein 1, 62kD (Downstream of Tyrosine Kinase 1) Gene
- [This gene plays a role in signal transduction and negative regulation of cell proliferation. ( NCI )] (UMLS (NCI) C1333246) DOK1;
DOK1 Gene;
=Gene or Genome ;
|
- 15. Docetaxel/Estramustine/Exisulind
- (UMLS (NCI) C1327846) =Therapeutic or Preventive Procedure; ;
| - 56. docosahexaenoic acid
- [C22-unsaturated fatty acids found predominantly in FISH OILS. ( MSH )] (UMLS (CSP) C0012968) =Lipid; Pharmacologic Substance; Biologically Active Substance =Fatty Acids, Omega-3;
Inactive Ingredient Preparations =DOCOSAHEXAENOIC ACID 120 MG/GM |
- 16. Docetaxel/Estramustine/Hydrocortisone
- (UMLS (NCI) C0393037) =Therapeutic or Preventive Procedure
| - 57. Doctor
- [individual qualified by education and legally authorized to practice medicine. ( CSP )] (UMLS (NCI) C0031831) =Professional or Occupational Group ;
=health care personnel;
RoleClass =general practitioner;
primary care physician;
|
- 17. Docetaxel/Estramustine/Mitoxantrone/Prednisone
- (UMLS (NCI) C0796411) EM/DHAD/PRED/TXT =Therapeutic or Preventive Procedure
| - 58. Doctor number
- (UMLS (HL7) C1549693) =Intellectual Product =Identifier type;
|
- 18. Docetaxel/Estramustine/Thalidomide
- (UMLS (NCI) C1134522) =Therapeutic or Preventive Procedure
| - 59. Doctor of Business Administration
- (UMLS (HL7) C1549964) =Intellectual Product =Degree/license/certificate;
|
- 19. Docetaxel/Exisulind
- (UMLS (NCI) C0935886) =Therapeutic or Preventive Procedure
| - 60. Doctor of Education
- (UMLS (HL7) C1549965) =Intellectual Product =Degree/license/certificate;
|
- 20. Docetaxel/Filgrastim/Gemcitabine
- (UMLS (NCI) C0935823) =Therapeutic or Preventive Procedure
| - 61. Doctor of Engineering
- (UMLS (HL7) C1549988) =Intellectual Product =Degree/license/certificate;
|
- 21. Docetaxel/Filgrastim/Trastuzumab/Vinorelbine
- (UMLS (NCI) C1134700) =Therapeutic or Preventive Procedure ;
| - 62. Doctor of Medicine
- [The Doctor of Medicine degree is the first-professional postgraduate degree that requires completion of a program that meets all of the following criteria: completion of the academic requirements to begin practice in the profession; at least 2 years of college work prior to entering the program; and a total of at least 6 academic years of college work to complete a program of studies in any branch of medical science, including prior required college work plus the length of the professional program itself. The academic standard is equivalent to Ph.D. science. ( NCI )] (UMLS (HL7) C1512018) M.D.;
MD =Intellectual Product =Degree/license/certificate;
|
- 22. Docetaxel/Filgrastim/Vinorelbine
- (UMLS (NCI) C0338252) =Therapeutic or Preventive Procedure
| - 63. Doctor of Osteopathy
- (UMLS (HL7) C1549967) =Intellectual Product =Degree/license/certificate;
|
- 23. Docetaxel/Filgrastim/XR9576
- (UMLS (NCI) C0935817) =Therapeutic or Preventive Procedure
| - 64. Doctor of Philosophy
- [The Doctor of Philosophy degree is the highest academic degree awarded in recognition of creative scholarship and research in a field of study. The recipient of this degree must have demonstrated proficiency in a broad area of learning and the ability to critically evaluate work in the discipline. The degree is not awarded solely for completing a prescribed number of courses, but for having undertaken and completed independent work in the discipline leading to an original contribution to knowledge. ( NCI )] (UMLS (HL7) C1512022) Ph.D.;
PhD =Intellectual Product ;
=Degree/license/certificate;
|
- 24. Docetaxel/Flavopiridol
- (UMLS (NCI) C0935851) =Therapeutic or Preventive Procedure
| - 65. Doctor of Science
- (UMLS (HL7) C1549989) =Intellectual Product =Degree/license/certificate;
|
- 25. Docetaxel/Fluorouracil/Leucovorin Calcium
- (UMLS (NCI) C0935821) =Therapeutic or Preventive Procedure
| - 66. Doctoral or post graduate education
- [Doctoral or post graduate education ( HL7V3.0 )] (UMLS (HL7) C1552037) =Idea or Concept =Education Level;
|
- 26. Docetaxel/Fowlpox-PSA Vaccine
- (UMLS (NCI) C1327777) =Therapeutic or Preventive Procedure ;
| - 67. Doctor_s Office Closed
- (UMLS (HL7) C1547234) =Intellectual Product =Case Category Code;
|
- 27. Docetaxel/Fowlpox-PSA Vaccine/Sargramostim
- (UMLS (NCI) C1327852) =Therapeutic or Preventive Procedure
| - 68. document
- [The notion of a document comes particularly from the paper world, where it corresponds to the contents recorded on discrete pieces of paper. In the electronic world, a document is a kind of composition that bears resemblance to their paper world counter-parts. Documents typically are meant to be human-readable. HL7's notion of document differs from that described in the W3C XML Recommendation, in which a document refers specifically to the contents that fall between the root element's start-tag and end-tag. Not all XML documents are HL7 documents. ( HL7V3.0 )] (UMLS (HL7) C1563337) =Idea or Concept ;
=Attestable unit;
=clinical document |
- 28. Docetaxel/Gefitinib
- (UMLS (NCI) C1327979) =Therapeutic or Preventive Procedure ;
| - 69. Document Availability Status
- (UMLS (HL7) C1547676) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Obsolete;
Available for patient care;
Unavailable for patient care;
Deleted |
- 29. Docetaxel/GEM 231
- (UMLS (NCI) C0796667) =Therapeutic or Preventive Procedure
| - 70. document body
- [A context that distinguishes the body of a document from the document header. This is seen, for instance, in HTML documents, which have discrete and elements. ( HL7V3.0 )] (UMLS (HL7) C1551342) =Idea or Concept ;
=organizer;
|
- 30. Docetaxel/Gemcitabine
- (UMLS (NCI) C0796493) TXT/dFdC;
=Therapeutic or Preventive Procedure ;
| - 71. Document completion status
- (UMLS (HL7) C1547674) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Authenticated;
Incomplete;
In Progress;
Legally authenticated;
Pre-authenticated;
Documented;
Dictated;
|
- 31. Docetaxel/GTI-2040
- (UMLS (NCI) C1328099) =Therapeutic or Preventive Procedure; ;
| - 72. Document Confidentiality Status
- (UMLS (HL7) C1547675) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Usual control;
Very restricted;
Restricted;
|
- 32. Docetaxel/Hypericum perforatum
- (UMLS (NCI) C1134709) =Therapeutic or Preventive Procedure ;
| - 73. Document response
- (UMLS (HL7) C1548021) =Idea or Concept =Message type;
|
- 33. Docetaxel/Ifosfamide
- (UMLS (NCI) C1134495) =Therapeutic or Preventive Procedure
| - 74. document section
- [A context that subdivides the body of a document. Document sections are typically used for human navigation, to give a reader a clue as to the expected content. Document sections are used to organize and provide consistency to the contents of a document body. Document sections can contain document sections and can contain entries. ( HL7V3.0 )] (UMLS (HL7) C1551341) Section;
=Idea or Concept ;
=organizer;
|
- 34. Docetaxel/Infliximab
- (UMLS (NCI) C1134703) =Therapeutic or Preventive Procedure ;
| - 75. Document Storage Status
- (UMLS (HL7) C1547677) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Active and archived;
Archived (not active);
Purged;
Active |
- 35. Docetaxel/Irinotecan
- (UMLS (NCI) C0796648) =Therapeutic or Preventive Procedure
| - 76. document verification
- [Verification by means of document. Example: Fax, letter, attachment to e-mail. ( HL7V3.0 )] (UMLS (HL7) C1699063) =Functional Concept =VerificationMethod;
|
- 36. Docetaxel/Ketoconazole
- (UMLS (NCI) C1134671) =Therapeutic or Preventive Procedure
| - 77. DocumentCompletion
- [Identifies the current completion state of a clinical document. ( HL7V3.0 )] (UMLS (HL7) C1553806) =Intellectual Product =CodeSystem;
=Authenticated;
Incomplete;
In Progress;
Legally authenticated;
Pre-authenticated;
Documented;
Dictated;
|
- 37. Docetaxel/Leuprolide/Testosterone
- (UMLS (NCI) C1328057) =Therapeutic or Preventive Procedure; ;
| - 78. Documented
- [A completion status in which document content, other than dictation, has been received but has not been translated into the final electronic format. Examples include paper documents, whether hand-written or typewritten, and intermediate electronic forms, such as voice to text. ( HL7V3.0 )] (UMLS (HL7) C1609436) =Idea or Concept =Document completion status;
DocumentCompletion |
- 38. Docetaxel/Methotrexate
- (UMLS (NCI) C0879466) =Therapeutic or Preventive Procedure ;
| - 79. Documented
- [Furnished with or supported by documents and documentation. ( NCI )] (UMLS (NCI) C1301725) =Health Care Activity; ;
|
- 39. Docetaxel/Mitoxantrone
- (UMLS (NCI) C0879303) =Therapeutic or Preventive Procedure
| - 80. documents
- [The source act documents the target act. ( HL7V3.0 )] (UMLS (HL7) C1548385) =Intellectual Product ;
=is sequel;
|
- 40. Docetaxel/MS-209
- (UMLS (NCI) C0879435) =Therapeutic or Preventive Procedure
| - 81. DocumentStorage
- [Identifies the storage status of a document. ( HL7V3.0 )] (UMLS (HL7) C1553807) =Intellectual Product =CodeSystem;
=Archived (not active);
Purged;
active;
|
- 41. Docetaxel/Oblimersen
- (UMLS (NCI) C0935709) =Therapeutic or Preventive Procedure
| |
home
